SonoThrombectomy™ System
Venous Thromboembolism (VTE) / Deep Vein Thrombosis (DVT)
Key Facts
About SonoVascular
SonoVascular is a clinical-stage medical device company pioneering an ultrasound and microbubble-enhanced approach to treating venous thromboembolism (VTE). Its core technology, the SonoThrombectomy™ Triple Action Clot Debulking Catheter System, is designed to disrupt the interventional VTE treatment market by offering a potentially superior alternative to current pharmacological thrombolysis and mechanical thrombectomy methods. The company has initiated first-in-human studies, secured strategic partnerships for microbubble supply, and completed an initial Series A financing round. With a seasoned leadership team and a prestigious scientific advisory board, SonoVascular is positioned to address a significant unmet need in cardiovascular care.
View full company profile